Koyfin Home > Directory > Health Care > Gilead Sciences Inc > Price / Tangible Book Value

Gilead Sciences Inc Price / Tangible Book Value Chart (GILD)

Gilead Sciences Inc annual/quarterly Price / Tangible Book Value from 2010 to 2020.
  • Gilead Sciences Inc Price / Tangible Book Value for the quarter ending October 10, 2020 was 175.57 a 37.43% increase of 65.71 year over year
  • Gilead Sciences Inc Price / Tangible Book Value for the last 12 months ending October 10, 2020 was 175.57 a 37.43% increase of 65.71 year over year
  • Gilead Sciences Inc Annual Price / Tangible Book Value for 2020 was 175.57 a -0.65% decrease of -1.15 from 2019
  • Gilead Sciences Inc Annual Price / Tangible Book Value for 2020 was 176.72 a -0.48% decrease of -0.86 from 2019
  • Gilead Sciences Inc Annual Price / Tangible Book Value for 2020 was 177.58 a 38.13% increase of 67.72 from 2019
Other Valuation Metrics:
  • Gilead Sciences Inc Market Cap for the quarter ending June 06, 2018 was $92,110m a -14.87% decrease of -13,696m year over year
  • Gilead Sciences Inc Price / Book for the quarter ending June 06, 2018 was 4.47 a -4.33% decrease of -0.19 year over year
  • Gilead Sciences Inc Enterprise Value for the quarter ending June 06, 2018 was $96,545m a -14.87% decrease of -14,361m year over year
View Chart On Koyfin

Quarterly GILD Price / Tangible Book Value Data

10/2020175.57
10/2020176.72
10/2020177.58
10/2020109.86
10/2020109.77
10/2020111.29
10/2020111.07
10/2020110.22
10/2020110.85
10/2020110.88

Annual GILD Price / Tangible Book Value Data

2020175.57
2020176.72
2020177.58
2020109.86
2020109.77
2020111.29
2020111.07
2020110.22
2020110.85
2020110.88